There has been no medical breakthrough for smoking cessation products since Chantix's launch in 2006, and this pill comes with many negative side effects. The first year of Chantix sales, Pfizer generated approximately $700 million. As of 2019, Chantix sales were approximately $1.1 Billion in US annual sales.
The US smoking cessation industry includes all FDA cleared nicotine replacement therapies and pharmaceuticals these products yield annual sales of $2.1 Billion, due to the 10 million out of the 34 million addicted US smokers attempting to quit smoking each year- It is important to note, only 5% of smokers using these methods to quit smoking succeed in doing so.
In addition,10 million people in the US are now vaping. and watch how quickly this new will rise within a year. There are 1,200 new cigarette smokers picking up the habit per day, and vaping is now one of the fastest growing global trends, and will surely create long term health effects. Sadly, many long-term smokers are now claiming to switch to vaping as a means of quitting smoking. Unfortunately these people still remain in the grasps of nicotine addiction.
FDA cleared anti-smoking products sold over the counter (OTC) generates approximately $1 billion in US sales annually, and vaping is not even considered in this figure, because electronic cigarettes are not considered a smoking cessation product or aid. These new e-cigarettes are a genius modern day nicotine delivery device.
Nicotine is highly addictive and electronic cigarettes are now the modern day cigarette. Many present smokers are transferring to vaping, chewing the nicotine gum or using the patch, but still remain addicted long after to the drug, instead of just quitting.
In our opinion, "You Don't Use Nicotine to Quit Nicotine."